Curanex Pharmaceuticals CURX
NASDAQ CURX
$4.92 -0.06 (-1.20%)
At close: Oct 2, 2026 · 4:00 PM EDT

Curanex Pharmaceuticals (CURX) Accumulated Expenses (2024 - 2026)

Updated

Curanex Pharmaceuticals (CURX) posted Accumulated Expenses of $9,741 for Q2 2026, compared with $575.00 a year earlier.

Analysis

Curanex Pharmaceuticals (CURX) Accumulated Expenses (2024 - 2026) Analysis & Trends

At the end of FY2025, Curanex Pharmaceuticals' Accumulated Expenses came in at $11,915, up 24.4% from FY2024.

  • In prior years, Curanex Pharmaceuticals' Accumulated Expenses was $9,575 in FY2024.
  • Quarterly Accumulated Expenses has run from a low of $575.00 in Q2 2025 to a high of $11,915 in Q4 2025 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Curanex Pharmaceuticals 7.06 Mn -6.79 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9,741.00
Dec 31, 2025 11,915.00
Sep 30, 2025 10,316.00
Jun 30, 2025 575.00
Dec 31, 2024 9,575.00
API Access

Curanex Pharmaceuticals Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=CURX&period=max&api_key=YOUR_API_KEY